Vascular Biogenics (STU:0VB) OCF Margin %: 0.00% (As of Jun. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Vascular Biogenics OCF Margin %?

Vascular Biogenics STU:0VB 10 OCF Margin % is 0.00% as of Jun. 2023. GuruFocus rates STU:0VB with a GF Score™ of 10/100. The stock has 5 warning signs investors should review.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Vascular Biogenics's Cash Flow from Operations for the three months ended in Jun. 2023 was €-2.18 Mil. Vascular Biogenics's Revenue for the three months ended in Jun. 2023 was €0.00 Mil. Therefore, Vascular Biogenics's OCF Margin % for the quarter that ended in Jun. 2023 was 0.00%.

As of today, Vascular Biogenics's current OCF Yield % is 0.00%.

The historical rank and industry rank for Vascular Biogenics's OCF Margin % or its related term are showing as below:


STU:0VB's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -65.71
* Ranked among companies with meaningful OCF Margin % only.

Vascular Biogenics OCF Margin % Related Terms

Vascular Biogenics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Vascular Biogenics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Vascular Biogenics OCF Margin % Chart

Vascular Biogenics Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
OCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2,681.52 -2,328.06 -2,535.22 -3,251.62 -4,802.74

Vascular Biogenics Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -15,127.87 -1,417.49 0.00 0.00 0.00

Vascular Biogenics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Vascular Biogenics's OCF Margin for the fiscal year that ended in Dec. 2022 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-29.825/0.621
=-4,802.74 %

Vascular Biogenics's OCF Margin for the quarter that ended in Jun. 2023 is calculated as

OCF Margin=Cash Flow from Operations (Q: Jun. 2023 )/Revenue (Q: Jun. 2023 )
=-2.18/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Vascular Biogenics (STU:0VB) has a OCF Margin % of 0.00% as of Jun. 2023. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Vascular Biogenics and its competitors.
Is Vascular Biogenics' OCF Margin % too high?
Vascular Biogenics' current OCF Margin % is 0.00%. Overall, Vascular Biogenics has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does Vascular Biogenics' OCF Margin % compare to MBIO and GNPX?
Vascular Biogenics' OCF Margin % of 0.00% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Vascular Biogenics and its competitors. Vascular Biogenics's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vascular Biogenics stock overvalued right now?
Vascular Biogenics (STU:0VB) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Vascular Biogenics' overall GF Score™ is 10/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Vascular Biogenics (STU:0VB), the current OCF Margin % is 0.00% as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Vascular Biogenics Business Description

Address 8 HaSatat Street, Modi’in, ISR, 7178106
Vascular Biogenics Ltd is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of first-in-class treatments for cancer. The lead product candidate of the company is VB-111 which is a gene-based biologic which is being developed for solid tumor indications for recurrent glioblastoma, an aggressive form of brain cancer. The company is also engaged in conducting a program targeting anti-inflammatory diseases, based on the use of Lecinoxoid platform technology. The product brands of the company include VTS, Vascular Targeting Systems, Vbl, Vascular Biogenics And Vascular Therapeutics.